CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.880
+0.110 (3.97%)
Aug 7, 2025, 4:00 PM - Market closed
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $36.62 million as of August 8, 2025. Its market cap has decreased by -36.56% in one year.
Market Cap
36.62M
Enterprise Value
28.73M
1-Year Change
-36.56%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since May 14, 2015, CollPlant Biotechnologies's market cap has increased from $29.72M to $36.62M, an increase of 23.24%. That is a compound annual growth rate of 2.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 35.22M | -14.58% |
| Dec 31, 2024 | 41.24M | -43.65% |
| Dec 29, 2023 | 73.18M | -21.52% |
| Dec 30, 2022 | 93.25M | -46.69% |
| Dec 31, 2021 | 174.91M | 147.09% |
| Dec 31, 2020 | 70.79M | 129.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |